Innoviva, Inc. · Drugmakers

INVA

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A high-quality, profitable business with growing sales.

Going well

Sales up 19% in the latest quarter vs a year ago
Profitable every year for 10 years
Sales up 15% last year

Money moves

No insider buying or selling in the last 30 days
Institutions added 0.2% to their holdings in the quarter ending June 2026 (178 bought, 104 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$21.05+1.9% that day

Company value: $1.5B; Share price times all shares
Price vs profit (P/E): 5.1x; You pay about $5 for each $1 of yearly profit
Price vs sales: 3.5x; Company value is 3.5 times a year of sales
Cash vs value: 38%; A big cushion: cash is a large part of what the company is worth
Debt vs value: 17%; Debt as a share of company value

From INVA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$119.6M+19% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $440.0M, up 19% from the 12 months before. Over 5 years, sales grew about 4.1% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of INVA. Starting points are the company's recent numbers.

Sales growth+19% a yearRecently: +19% a yearProfit margin50%Last 12 months: 81.2%P/E at the end8xToday: 5.1x. Many steady companies trade at 12x to 25xShare count change-4% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$1.0B

Profit in 5 years$525M

Price these guesses point to$71.30+239% vs $21.05 todayAbout +28% a year, before dividends

What today's price needs: with a 50% margin and a 8x P/E, sales could shrink about 6.8% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

7/7Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.29.1%
PassDebt under half of equityNot relying on borrowed money.0.22x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.65.9%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$195.8M
PassShare count not growingNot diluting owners. Falling means buybacks.-11.0% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.74.8%

Revenue: $411.3M; +14.7% vs prior year
5-year growth: +4.1%/yr; revenue, per year
Total debt: $257.7M; 0.22x equity
Current ratio: 14.64x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.